Member area

AGO 35

share this :
Below please find
  • PI: Florentia Peintinger
  • study supported by EUBREAST
  • trial design:  prospective observational trail
  • primary endpoint: probability of achieving a negative axillary node status. Prospective validation of genomic signatures to predict treatment response in the axillary nodes after neoadjuvant chemotherapy in patients with HER2-negative breast cancer.
Read more
Become a member to stay updated!
The Benefits of EUBREAST Membership
Enter into a network of renowned international breast surgeons
Access to detailed information on ongoing and previous projects and events
Take part in international cross-border studies
Publish your EUBREAST membership status on your website / social media platforms together with the respective logo.
Become a Member
Apply online
click here
I'm already a member, log me in

Become a Donor

Become a Member

Linkedin Twitter Facebook-f Instagram
©2024 . EUBREAST. All rights reserved